Onesource Specialty Pharma Ltd. (ONESOURCE.NS) AI-Powered Stock Analysis
See how Onesource Specialty Pharma Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
ONESOURCE.NS●NSE
HealthcareBiotechnology
₹1542.00
₹22.000(1.41%)
Indian Market opens in 49h 14m
Advertisement
Onesource Specialty Pharma Ltd. (ONESOURCE.NS)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerOnesource Specialty Pharma Ltd. (ONESOURCE.NS) Stock Overall Grade
Onesource Specialty Pharma Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Onesource Specialty Pharma Ltd.'s overall stock rating.
Forecast
A+Score
100/100Financial Growth
CScore
40/100Fundamental Growth
CScore
45/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Onesource Specialty Pharma Ltd. (ONESOURCE.NS) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 100/100 (A+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (45/100, C) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Onesource Specialty Pharma Ltd. stock grade, including financials, comparisons, and forecasts.